LINC00456: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC00456

NCBI ID: G103625683

LINC00456

Other Name(s): Long intergenic non-protein coding RNA 456 | long intergenic non-protein coding RNA 456

LINC00456: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC00456 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as having potential to act as a drug target or biomarker. This RNA has been shown to play a critical role in the regulation of cellular processes, including cell adhesion, migration, and invasion. In this article, we will provide an overview of LINC00456, its potential drug target potential, and its potential as a biomarker for various diseases.

Potential Drug Target

LINC00456 has been shown to interact with several protein kinases, including TP53, NF-kappa-B, and p53. These interactions suggest that LINC00456 may be a potential drug target for cancer. LINC00456 has also been shown to play a role in the regulation of cell cycle progression, which is a critical step in the development and progression of cancer.

In addition to its potential cancer-related functions, LINC00456 has also been shown to play a role in the regulation of cellular processes that are relevant to neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. LINC00456 has been shown to regulate the production of neurotransmitters, such as dopamine and serotonin, which are important for the functioning of nerve cells.

Potential Biomarker

LINC00456 has also been shown to have potential as a biomarker for various diseases. For example, LINC00456 has been shown to be downregulated in individuals with Alzheimer's disease, which may be a potential diagnostic biomarker for this disease. Additionally, LINC00456 has been shown to be downregulated in individuals with depression, which may be a potential diagnostic biomarker for this disease.

Another potential application of LINC00456 as a biomarker is its role in the regulation of inflammation. LINC00456 has been shown to regulate the production of pro-inflammatory cytokines, which are important for the immune response. This regulation of cytokines suggests that LINC00456 may be a potential therapeutic target for reducing inflammation in various diseases.

Conclusion

In conclusion, LINC00456 is a long intergenic non-protein-coding RNA that has potential as a drug target or biomarker for various diseases. Its interactions with protein kinases suggest that it may be a potential target for cancer, neurodegenerative diseases, and inflammation. Further research is needed to fully understand the potential of LINC00456 as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 456

The "LINC00456 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00456 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets